442 related articles for article (PubMed ID: 19102385)
1. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center.
Abdel-Wahab M; El-Ghawalby N; Mostafa M; Sultan A; El-Sadany M; Fathy O; Salah T; Ezzat F
Hepatogastroenterology; 2007; 54(73):157-62. PubMed ID: 17419252
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of hilar cholangiocarcinoma in Egypt: single center study.
Abdel Wahab M; Mostafa M; Salah T; Fouud A; Kandeel T; Elshobary M; Abd Allah OF; Elghawalby N; Sultan A; Ezzat F
Hepatogastroenterology; 2007 Sep; 54(78):1626-31. PubMed ID: 18019680
[TBL] [Abstract][Full Text] [Related]
4. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention.
Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA
Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933
[TBL] [Abstract][Full Text] [Related]
5. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
6. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
7. Does aflatoxin B1 play a role in the etiology of hepatocellular carcinoma in the United States?
Hoque A; Patt YZ; Yoffe B; Groopman JD; Greenblatt MS; Zhang YJ; Santella RM
Nutr Cancer; 1999; 35(1):27-33. PubMed ID: 10624703
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
10. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
[TBL] [Abstract][Full Text] [Related]
11. [Synergism of three risk factors in hepatocellular carcinogenicity].
Zhou Y; Peng W; Yao J
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Sep; 30(5):289-91. PubMed ID: 9388889
[TBL] [Abstract][Full Text] [Related]
12. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center.
Abdel-Wahab M; el-Enein AA; Abou-Zeid M; el-Fiky A; Abdallah T; Fawzy M; Fouad A; Sultan A; Fathy O; el-Ebidy G; elghawalby N; Ezzat F
Hepatogastroenterology; 2000; 47(33):663-8. PubMed ID: 10919007
[TBL] [Abstract][Full Text] [Related]
15. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against ox-LDL serum levels in patients with hepatocellular carcinoma.
Motta M; Pistone G; Franzone AM; Romeo MA; Di Mauro S; Giugno I; Ruello P; Malaguarnera M
Panminerva Med; 2003 Mar; 45(1):69-73. PubMed ID: 12682623
[TBL] [Abstract][Full Text] [Related]
17. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
Yu MW; Lien JP; Liaw YF; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
[TBL] [Abstract][Full Text] [Related]
18. Role of hepatitis B virus infection in the prognosis after hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a Western dual-center experience.
Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Ravaioli M; Zanello M; Andreone P; Capussotti L; Pinna AD
Arch Surg; 2009 Oct; 144(10):906-13. PubMed ID: 19841357
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of molecular dosimetry: individual versus group effects of oltipraz on aflatoxin-albumin adducts and risk of liver cancer.
Kensler TW; Gange SJ; Egner PA; Dolan PM; Muñoz A; Groopman JD; Rogers AE; Roebuck BD
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):603-10. PubMed ID: 9264273
[TBL] [Abstract][Full Text] [Related]
20. Aflatoxin B1 DNA adducts in smeared tumor tissue from patients with hepatocellular carcinoma.
Chen CJ; Zhang YJ; Lu SN; Santella RM
Hepatology; 1992 Nov; 16(5):1150-5. PubMed ID: 1385290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
